Cargando…
Lipoxin (LX)A(4) and Aspirin-triggered 15-epi-LXA(4) Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis
The impact of lipoxin A(4) (LXA(4)) and aspirin-triggered lipoxins (ATLs) was investigated in tumor necrosis factor (TNF)-α–initiated neutrophil (polymorphonuclear leukocyte) responses in vitro and in vivo using metabolically stable LX analogues. At concentrations as low as 1–10 nM, the LXA(4) and...
Autores principales: | Hachicha, Mohamed, Pouliot, Marc, Petasis, Nicos A., Serhan, Charles N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192964/ https://www.ncbi.nlm.nih.gov/pubmed/10377187 |
Ejemplares similares
-
Aspirin-triggered 15-Epi-Lipoxin A(4) (LXA(4)) and LXA(4) Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors
por: Takano, Tomoko, et al.
Publicado: (1997) -
Lipid-Derived Mediators in Endogenous Anti-Inflammation and Resolution: Lipoxins and Aspirin-Triggered 15-epi-Lipoxins
por: Serhan, Charles N., et al.
Publicado: (2002) -
Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome
por: He, Jiucheng, et al.
Publicado: (2023) -
15-Epi-LXA(4) and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation
por: Sekheri, Meriem, et al.
Publicado: (2020) -
Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
por: Svensson, Camilla I., et al.
Publicado: (2007)